Bioqual Return on Tangible Equity 2010-2023 | BIOQ

Current and historical return on tangible equity values for Bioqual (BIOQ) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Bioqual Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-11-30 $-0.00B $0.04B -2.68%
2023-08-31 $0.00B $0.04B 0.00%
2023-05-31 $0.00B $0.04B 0.00%
2023-02-28 $0.00B $0.04B 8.00%
2022-11-30 $0.01B $0.04B 13.51%
2022-08-31 $0.01B $0.04B 13.89%
2022-05-31 $0.01B $0.04B 14.29%
2022-02-28 $0.01B $0.04B 14.71%
2021-11-30 $0.01B $0.03B 15.27%
2021-08-31 $0.01B $0.03B 15.87%
2021-05-31 $0.01B $0.03B 19.83%
2021-02-28 $0.01B $0.03B 17.39%
2020-11-30 $0.01B $0.03B 18.02%
2020-08-31 $0.01B $0.03B 18.69%
2020-05-31 $0.00B $0.03B 20.51%
2020-02-29 $0.00B $0.03B 33.33%
2019-11-30 $0.00B $0.03B 54.55%
2019-08-31 $0.00B -400.00%
2019-05-31 $0.00B $-0.00B -400.00%
2019-02-28 $0.00B 57.14%
2018-11-30 $0.00B 76.19%
2018-08-31 $0.00B 76.19%
2018-05-31 $0.00B $0.02B 76.19%
2018-02-28 $0.00B inf%
2017-11-30 $0.00B inf%
2017-08-31 $0.00B inf%
2017-05-31 $0.00B inf%
2017-02-28 $0.00B inf%
2016-11-30 $0.00B inf%
2016-08-31 $0.00B inf%
2016-05-31 $0.00B inf%
2016-02-29 $0.00B inf%
2015-11-30 $0.00B inf%
2015-08-31 $0.00B inf%
2015-05-31 $0.00B inf%
2015-02-28 $0.00B nan%
2014-08-31 $0.00B nan%
2014-05-31 $0.00B nan%
2013-11-30 $0.00B nan%
2013-08-31 $0.00B nan%
2013-05-31 $0.00B nan%
2012-05-31 $0.00B nan%
2012-02-29 $0.00B nan%
2011-11-30 $0.00B nan%
2011-08-31 $0.00B nan%
2011-05-31 $0.00B nan%
2011-02-28 $0.00B nan%
2010-11-30 $0.00B nan%
2010-08-31 $0.00B nan%
2010-05-31 $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.063B
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.403B 10.53
Quest Diagnostics (DGX) United States $15.823B 16.35
DaVita (DVA) United States $11.969B 14.87
Chemed (CHE) United States $8.605B 26.67
Encompass Health (EHC) United States $8.603B 22.02
Elanco Animal Health (ELAN) United States $8.391B 21.77
Option Care Health (OPCH) United States $5.187B 19.63
RadNet (RDNT) United States $4.254B 88.58
Amedisys (AMED) United States $3.103B 21.98
LifeStance Health (LFST) United States $2.817B 0.00
Astrana Health (ASTH) United States $2.304B 31.16
Addus HomeCare (ADUS) United States $1.805B 25.83
U.S Physical Therapy (USPH) United States $1.601B 42.84
Pennant (PNTG) United States $0.673B 35.57
Aveanna Healthcare Holdings (AVAH) United States $0.510B 0.00
Atai Life Sciences (ATAI) Germany $0.311B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00